Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy
暂无分享，去创建一个
C. Siao | L. Macdonald | A. Murphy | G. Yancopoulos | I. Lowy | G. Thurston | W. Olson | Lauric Haber | M. Sleeman | W. Poueymirou | John C. Lin | Arpita Pawashe | S. Yang | Aynur Hermann | E. Ullman | A. Rafique | R. Babb | Gang Chen | C. Daly | D. Ajithdoss | V. Kamat | D. Skokos | Rabih Slim | Xuan Ye | Bei Wang | Qi Wu | Ilyssa Ramos | Lauren Canova | E. Herlihy | Hassan Ahmed | E. Oswald | Jacquelynn Golubov | P. Poon | Julie Kim | Jacqueline J Warsaw | Nicole Stokes Oristian | Drew Dudgeon | Joel Martin | D. MacDonald | Eric J. Smith | C. Gurer | P. Krueger | Randi L Foster | Jennifer Finney | Jenny Xiao | E. Navarro | E. Garnova | Devon Grote | Clarissa Lett | Janelle C. Waite | Stephen Godin | Jennifer Stella | Amanda Dorvilliers | Teresa Schulenburg | A. Hermann | Erica Ullman